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INTRODUCTION
Streptococcus pneumoniae, also known as the pneumococcus, is the most common cause of bacterial pneumonia, and can cause otitis media and meningitis in children, the elderly and immunocompromised patients (Lundbo and Benfield 2017) .
Systemic streptococcal infections, such as invasive pneumonia, sepsis and meningitis are also known as inflammatory pneumococcal disease (IPD) . From 2009 to 2011, 16% of diagnosed and hospitalized IPD patients in Belgium died during hospitalization (Verhaegen et al. 2014) . In case of comorbidities, such as heart failure or renal insufficiency, a mortality rate of 20% was reported. These high mortality rates are partially due to ineffective treatments. Bacterial resistance towards first line antibiotics makes treating S. pneumoniae infections difficult (World Health Organisation (WHO) 2014). Moreover, vaccination does not have a positive outcome on pneumococcal pneumonia and has only proven to be effective for other IPDs for the vaccinated serotypes and some crossovers (Huss et al. 2009 ). It has been observed that less common serotypes are replacing the ones used in vaccination (Vestjens et al. 2017) .
The pneumococcus has developed a wide range of virulence factors to evade the immune system. The most important virulence factor is the polysaccharide capsule (Kadioglu et al. 2008) . This capsule inhibits opsonization and subsequent macrophage phagocytosis through limitation of C3b/iC3b deposition (Hyams et al. 2010) . In addition, the presence of the surrounding capsule restricts the serotype specific availability of antigens required for T-cell activation (Dockrell, Whyte and Mitchell 2012) . In the pathogenesis of pneumonia, alveolar macrophages form the first line of defense to pneumococcal invasion (Dockrell et al. 2003; Dockrell, Whyte and Mitchell 2012) . Deletion of the capsule has been shown to increase the phagocytosis rate in vitro and decrease virulence in vivo (Preston and Dockrell 2008) . In contrast, non-encapsulated pneumococci show better adherence properties and an increase in biofilm formation, which is considered to be a part of the pneumococcal immune evasion strategy during pneumonia and otitis media (Domenech et al. 2013; Chao et al. 2015) . Additionally, during nasopharyngeal colonization a decrease in capsule production is also observed. This could be due to its need for attachment. However, when the change from a commensal to a pathogenic lifestyle occurs, streptococci upregulate the formation of capsular polysacharides, which is likely due to the importance of the capsule in evading the immune system (Gilley and Orihuela 2014) .
The main gene locus designated for capsule production is the cps locus, a highly variable region which gives rise to over 90 different pneumococcal serotypes (Geno et al. 2015) . However, it is known that other genes are also involved in the regulation of capsule production (Llull et al. 1999) . Regardless of the serotype, uridine diphosphate glucose (UDP-Glc) is a key component in the formation of a capsule. UDP-Glc is part of the glucose (Glc) and galactose (Gal) metabolism, where uridine diphosphate glucose pyrophosphorylase (UDPG:PP, EC 2.7.7.9) reversibly converts UDP-Glc to glucose-1-phosphate (Glc-1-P). UDPG:PP is encoded by the galU gene locus and is highly conserved between different bacterial species. Mutants lacking a functional galU gene do not form any detectable amounts of capsular polysaccharides, due to their inability to interconvert Gal and Glc (Mollerach, López and García 1998) .
As UDPG:PP is present in presumably all pneumococcal serotypes and deletion of the underlying gene deprives them of their most important virulence factor, this enzyme could present a potential effective drug target for the treatment of pneumococcal diseases. Furthermore, prokaryotic UDPG:PPs are structurally unrelated to their eukaryotic counterparts (FloresDíaz et al. 1997; Berbís et al. 2015) . This suggests that inhibition of bacterial UDPG:PP would not be harmful to the host, such as humans. UDPG:PP and UDP-Glc do not only play a role in the capsular polysaccharide pathway. In other bacteria, UDP-Glc is also involved in other functional pathways, such as those involving sugar metabolism and stress responses (Berbís et al. 2015) . In this study, we investigated the role of a mutation in the galU locus in pneumococcal virulence. We deter- mined the impact of a mutation of galU on in vitro adherence to lung epithelial cells and macrophages and phagocytosis in macrophages. As we found an effect on adherence, and this is the first step towards chronic biofilm infections, we also investigated biofilm formation. Additionally, to assess the effect of a galU mutation on in vivo virulence, a Galleria mellonella larvae model was also used. Our data demonstrate that a galU mutation impacts streptococcal interactions with host cells and overall virulence. These characteristics make this gene an interesting and potentially effective target for novel antimicrobial drug discovery.
MATERIALS AND METHODS

Bacterial strains and cell cultures
S. pneumoniae strains listed in Table 1 were a kind gift from Prof. Mollerach, Universidad de Buenos Aires, Argentina. Briefly, mutants were obtained through an interruption in the last 102 nucleotides of the gene by mariner mutagenesis leading to deletion of the last 33 C-terminal amino acids of the enzyme as described previously (Mollerach, López and García 1998; Martin et al. 2000) . Disorganization of the enzyme tetramer has been confirmed with theoretical 3D modeling of native and truncated enzyme using the SWISS-MODEL program (data not shown) (Schwede et al. 2003 and grown in RPMI-1640 medium supplemented with 10% iFCS (all from Sigma) under the same conditions.
Planktonic growth
Planktonic growth curves were obtained over a 10 h period. All strains were grown in BHI broth at 37 • C and 5% CO 2 as advised by ATCC R . At 2-h intervals, the concentration was determined by viable plate count and the optical density was measured using a cell density meter at 600 nm with 10 mm path length (Biochrom WPA CO8000).
Biofilm growth
Biofilm growth was set up in polystyrene 96-well plates (Greiner Bio-One). In each well, 150 μl of a bacterial culture with a concentration of 10 6 CFU mL −1 in Mueller-Hinton broth (MHB) (Sigma-Aldrich) supplemented with 5% lysed horse blood (Oxoid) was added (Vandevelde, Tulkens and Van Bambeke 2014) . Plates were wrapped in parafilm to counteract evaporation and incubated at 37
• C and 5% CO 2 for 24 or 48 h.
After incubation, the medium was discarded and wells were washed with phosphate-buffered saline (PBS) (Life Technologies). Then biofilms were fixed with methanol (Merck), stained with 200 μl 0.01% crystal violet (Merck) and eluted with 33% acetic acid (Merck) as described previously (Toté et al. 2009 ). Absorbance was measured using a spectrophotometer at 570 nm (Labsystems Multiskan R MCC/340). For this assay, strain TIGR4 was used as a reference strain for biofilm formation (Lizcano et al. 2010) .
Biofilm attachment
To assess the first step of biofilm formation, suspensions were made as described previously (see section biofilm growth). After 4 h of incubation, wells were washed twice with PBS. Subsequently, attached bacteria were detached using 0.5% saponin (Riedel-de Haën). The number of attached bacteria was determined by viable plate count. For this assay, strain TIGR4 was used as a reference strain for biofilm formation (Lizcano et al. 2010) .
Antibiotic activity
Minimal inhibitory concentrations (MIC) of standard antibiotics were determined using a resazurin assay as described previously (Torfs et al. 2018) . The antibiotics that were used were: erythromycin (Sigma-Aldrich), amoxicillin (Sigma-Aldrich), doxycycline (Sigma-Aldrich), cefuroxime (CRS) and moxifloxacin (Fluka). Briefly, 100 μl of a 1:2 serial dilution series of antibiotics in BHI broth was added to 96-well plates, after which bacteria were added to final concentration of 2.5 * 10 5 CFU mL −1 in 200 μl. After 20 h of incubation at 37 • C and 5% CO 2 , 20 μl of 0.005% resazurin was added. After an additional incubation of 90 min, fluorescence was measured at λ emission = 590 nm, λ excitation = 550 nm using a spectrophotometer (Promega Discover).
Epithelial adherence assay
Epithelial cells were grown to confluency for 24h at 37
• C and 5% CO 2 in polystyrene 24-well plates. Pneumococcal cells were grown to mid log phase in BHI broth and diluted to obtain a multiplicity of infection (MOI) of 20 in DMEM supplemented with 1% glutamine and 10% iFCS (Letourneau et al. 2011) . After 90 min of co-incubation, cells were washed three times with pre-warmed PBS to remove unbound bacteria. Adherent bacteria were detached using 0.5% saponin. The number of adherent bacteria was determined by viable plate count.
Macrophage assay
RAW264.7 cells were seeded into polystyrene 24-well plates at 2 * 10 5 cells per well and incubated at 37
• C and 5% CO 2 , 24 h prior to infection. Bacteria were grown as described earlier for 4 h prior to infection. Bacteria were added to cells at an MOI of 10 in DMEM + 10% iFCS as described previously (Domon et al. 2016) . Plates were incubated for 90 min at 37
• C and 5% CO 2 .
Cells were washed twice with PBS/Ca 2+ Mg 2+ to wash away all loose bacteria. For determination of intracellular bacteria, 50 mg mL −1 gentamicin (Life Technologies) was added at 200 μl mL
in DMEM + 10% iFCS. Cells were incubated for 60 min at 37 • C and 5% CO 2 to kill all extracellular bacteria. Afterwards, cells were lysed using 200 μl 0.1% Triton X-100 (Sigma-Aldrich) for 10 minutes at room temperature and the concentration of internal bacteria was determined using the viable plate count method.
To determine the total amount of intracellular and adhered bacteria, 200 μl 0.1% Triton X-100 was added directly after washing the cells and the concentration was determined by viable plate count.
FITC-dextran exclusion assay
The degree of encapsulation was determined by measuring the zone of exclusion of FITC-dextran (2000 kDa, Sigma-Aldrich), as described previously (Gates, Thorkildson and Kozel 2004; Weinberger et al. 2009 ). Briefly, bacteria were grown as described earlier until logarithmic phase, centrifuged for 5 min at 3000 g and resuspended in 500 μl PBS. To 100 μl of bacterial suspension 20 μl FITC-dextran (10 μg/mL in water) and 10 μl of this suspension was used to create wet mounts with cover slips. The slides were viewed on a Zeiss Observer.Z1 microscope with a 100x objective, and fluorescent images were captured with a Zeiss AxioCam MRm camera. The images were converted into greyscale and analyzed using ImageJ software. The area of FITC exclusion was determined. A brightfield image was also photographed for each fluorescent images recorded in order to count the number of bacteria per chain. For each strain, the mean of 150-300 cells was determined, and at least two images were collected from each of at least two independently prepared slides.
Galleria mellonella killing assay
Larvae were purchased from a local vendor (Anaconda Reptiles, Kontich, Belgium) and stored in wood chips at 15
• C before use.
Four hours before use, larvae were put at 4 • C. A sterile 20 μl
Hamilton syringe was used to inject 10 μl aliquots of bacterial suspensions into the hindmost left proleg of G. mellonella. Larvae were infected with 10 4 , 10 5 or 10 6 CFU per larvae, with a minimum of 15 larvae per group. The control group was injected with 10 μl PBS. Following the injections, larvae were incubated at 37
• C in the dark for several days to allow the progression of the pneumococcal infection. Every 24 h, larvae were scored as dead or alive. Larvae were determined dead when no signs of movement could be observed in response to external stimuli and when the larvae showed dark pigmentation due to melanization. For each strain, 5 independent repeats were carried out.
Statistical analyses
Data were analyzed for statistical significance using Graphpad Prism Version 6. Continuous variables were compared by twoway Anova, t-test or survival analyses. Statistical significance was defined as P < 0.05. Statistical significance between two groups is mentioned as asterisks in figures ( * P ≤ 0.05; * * P ≤ 0.01; * * * P ≤ 0.001; * * * * P ≤ 0.0001). 
RESULTS
In vitro characterization of galU mutational strains: Planktonic growth and susceptibility to standard antibiotics
As UDPG:PP is part of the glucose and galactose pathway, a conformational mutation of this enzyme could lead to an overall change in metabolic state. To test this hypothesis, planktonic growth and antimicrobial susceptibility were investigated. No difference in planktonic growth between streptococcal strains with the galU mutation and their non-mutated wild type strains was observed in strain 85 and 88 (Fig. 1) . For strain M23, an increase in planktonic growth was observed for the mutant strain, while strain R6 was slightly growth impaired when the mutation was present. Also, the susceptibility to standard antibiotics remained the same in most wild type and mutant strains (Table 2) . However, for strain R6 the susceptibility towards β-lactam antibiotics amoxicillin and cefuroxime increased over a 100-fold when the galU mutation was present. Taken together, these results suggest that no changes in planktonic metabolic state occur due to an effect of the mutation in encapsulated strains, but galU mutation has an influence on already non-encapsulated strains.
Production of polysaccharide capsule in mutants
To assess the effect of the galU mutation on the polysaccharide capsule, a FITC-dextran exclusion assay was performed. Our results showed that the mutation had no effect on the size of strain R6 (P = 0.0797), which was already non-encapsulated, while there is a significant difference in size for all other strains compared to their mutated counterparts (85 vs. mutated 85 P < 0.0001, 88 vs. mutated 88 P < 0.0001, M23 vs. mutated M23 P < 0.0001) (Figs 2-3) . Also, the effect of the galU mutation differs between the strains, with mutant strain 85 being completely capsule deficient. However, mutant strain 88 is capsule attenuated but not deficient and mutant strain M23 being the least capsule attenuated.
Biofilm formation in vitro
The biofilm formation was dependent on incubation time and serotype (Fig. 4) . Strain 85 and strain R6 showed no differences in biomass between wild type and mutant strain at 24 h, but the biomass of the mutant strains significantly increased at 48 h. For strain 88, no difference in biomass was observed after 48 h (P = 0.5977). For strain M23, an increase was observed at 24 and 48 h of incubation (P < 0.0001 at both time points). Compared to the reference strain TIGR4, which is a strain with good biofilmforming capacities, strain M23 was a non-biofilm forming strain but it changed into a good biofilm former when the mutation was in place (Lizcano et al. 2010) . Strain 85, which also is a biofilm former compared to the reference strain TIGR4, became an even better biofilm former at 48 h when mutated (P = 0.0150). The same effect was observed for strain R6 (P < 0.0001). Overall, differences in biomass at 24 h are small and probably not biologically relevant. Since planktonic growth was unaltered in almost the strains (Fig. 1) , the increase in biomass is hypothesized to be due to a difference in initial attachment rather than a difference in metabolism. However, we showed that the mutation leads to an increase in attachment for strains 88 and M23 but not for strain 85 and R6 (Fig. 5) , thus there is no clear correlation between primary attachment and biomass.
In vitro adherence to epithelial cells and macrophage phagocytosis
The polysaccharide capsule is known to prevent bacterial adherence and phagocytosis of immune cells. Loss of this capsule makes bacteria more prone to interactions with the host. This was confirmed in our experiments, where non-encapsulated wild type strain R6 adhered significantly better compared to wild type strain 85 (P = 0.0048), strain 88 (P = 0.0032) and strain M23 (P = 0.0004). This strain also produced most biomass in previous experiments (Fig. 4) . Furthermore, a significant increase in adhesion of bacteria with the galU mutation to A549 epithelial cells was observed for all strains (Fig. 6) . On RAW264.7 macrophage-like cells, the adherence and phagocytosis of wild type strains was even more serotype specific, showing a significant difference between almost all wild type strains (85 vs. 88 P = 0.0006, 85 vs. M23 P < 0.0001, 88 vs. M23 P < 0.0001, 85 vs. R6 P = 0.2996 (ns), 88 vs. R6 P = 0.0012, M23 vs. R6 P < 0.0001) (Fig. 7) . In accordance with the previous results using an epithelial cell line, all mutants showed an increased adherence and phagocytosis compared to their respective wild type strains.
After gentamicin treatment, all mutants showed an increased phagocytosis compared to their wild type strains. Strain M23 was the least adherent and phagocytosed strain, which is also the strain that produced the thickest polysaccharide capsule and was the least adherent strain in biofilm experiments (Fig. 2,  Fig. 4) . After calculating the ratio of phagocytosed bacteria to total number of bacteria in mutant and parent strains, a higher ratio in mutants compared to parent strains could be observed. Furthermore, there was a clear increase in attachment and phagocytosis between parent and mutant strain. However, in all cases the increase was lowest for strain M23 and highest for strain R6. The difference between strains 85 and 88 were less pronounced (Table S1 , Supporting Information).
In vivo pathogenicity
The G. mellonella infection model was used to investigate pathogenicity of the mutant strains (Fig. 8) . Survival of G. mellonella larvae infected with mutant strains was significantly lower than those infected with mutant strains, independent of the serotype. Furthermore, there was a difference between the different serotypes. Strain M23 was found to be more virulent than strains 85 and 88. Only for avirulent strain R6, there was no difference between the wild type and the mutated strain.
DISCUSSION AND CONCLUSION
The galU gene codes for a UDPG:PP which is known to be involved in the UDP-glucose metabolism of prokaryotes and is needed for the biosynthesis of lipopolysaccharides, capsular polysaccharides and membrane derived oligosaccharides in other bacteria, such as E. coli and P. aeruginosa (Hyams et al. 2010; Dockrell, Whyte and Mitchell 2012) . In S. thermophiles, the galU gene has been identified as an important gene in exopolysaccharide (EPS) production (Levander, Svensson and Rådström 2002) . For other streptococcal species, such as S. mitis and S. oralis, a homologous gene has been identified (Mollerach and García 2000) . In humans and other mammals, galU is also present. However, these UDPG:PPs are evolutionarily unrelated to their prokaryotic counterparts, while they do show homology with other eukaryotic UPDG:PPs (Flores-Díaz et al. 1997; Berbís et al. 2015) . In S. pneumoniae, UDPG:PPs are found both in the capsule gene locus and outside of this locus. In contrast to UPDG:PP inside the capsule gene locus, the gene outside the capsule locus has been shown to be irreplaceable for polysaccharide capsule production (Dockrell et al. 2003; Preston and Dockrell 2008) . To date, apart from the effect on the streptococcal capsule, it has been shown that a galU mutant is attenuated for lung colonization and is unable to infect the blood following intranasal instillation in mice. Furthermore, this mutant is capable of infecting the middle ear of gerbils without dissemination in the blood stream, but with dissemination towards cerebrospinal fluid and brains (Marra and Brigham 2001) . Prokaryotic UDPG:PPs are rapidly gaining interest as target candidates for novel antimicrobial therapies. The determination of the effects of a galU mutation on the interactions with the host will provide some much needed insight and could aid the search for novel antimicrobial targets (Berbís et al. 2015; Zavala et al. 2017) . In this study, the effect of a galU mutation on host cell interactions was investigated using in vitro cell lines and an in vivo G. mellonella model. This mutation leads to a better phagocytosis of bacteria by macrophages, an increased adherence on different cell lines and a decreased virulence when compared to the effects of encapsulated parent strains. In a previous study, the galU mutation was shown to result in non-encapsulated streptococci (Mollerach, López and García 1998) . However, thus far no further research has been conducted on this specific mutation. Deletion or attenuation of the capsule in this manner will most likely highly influence the adherence to epithelial cells and macrophages, since these results in exposure of adhesive surface molecules (Hammerschmidt et al. 2005; Hyams et al. 2010) . In this study, we showed that all UDPG:PP mutated strains indeed showed a significant increase in adhesion to epithelial cells. In macrophages, the number of phagocytosed bacteria was also significantly increased. Non-encapsulated parent strain R6 showed the highest adhesion and phagocytosis rates compared to other parent strains. All these in vitro data are in line with previous studies, where loss of capsule due to other, non-related, gene mutations in S. pneumoniae was investigated (Hammerschmidt et al. 2005; Gupta et al. 2013; Schaffner et al. 2014) . However, the increase in adhesion and phagocytosis of the mutated R6 strain indicates an additional effect of the mutation, apart from the decrease in polysaccharide capsule. For other bacterial species, the effect of the galU gene product on virulence has already been investigated. In E. coli, the galU gene has been shown to play an important role in uropathogenesis. Mutants lacking a functional galU gene triggered a more intense cytokine response of macrophages in vitro, without affecting the bacterial growth or cytotoxicity towards macrophages (Meyer et al. 2015) .
In vivo, it has been demonstrated that streptococci lacking a capsule are significantly less virulent than encapsulated bacteria (Wessels et al. 1991) . Additionally, a galU mutation in non-streptococcal bacterial species has been shown to decrease virulence in both animal-pathogenic and plant-pathogenic bacteria (Priebe et al. 2004; Liao et al. 2014) . In this study, the G. mellonella model complies with these previous findings. Furthermore, this model confirms the results of the in vitro experiments, where mutants are more readily adhered and phagocytosed by immune cells than their wild type strains. For avirulent strain R6, no difference in in vivo pathogenicity is observed. In previous studies, the absence of a polysaccharide capsule, unrelated to the galU gene, has been linked to an increase in streptococcal biofilm formation (Moscoso, Garcia and Lopez 2006; Domenech, García and Moscoso 2012) . In this study, an effect of the galU mutation on biofilm formation was observed for the first time. Interestingly, this trend was not apparent for all streptococcal strains. These findings suggest that there are likely also other factors, associated with the functionality of the galU gene product, which play a role in biofilm formation (Moscoso, Garcia and Lopez 2006) . The number of attached bacteria after 4 h of incubation was elevated in all mutant strains, as it was in host cell-associated assays. However, we found no correlation between this increase and the differences in biofilm biomass. The link between capsule expression and initial attachment has been studied extensively before, but no clear trend emerged from these studies. For example, in a study conducted by Moscoso et al., a downregulation of capsule led to an increase in attachment while Oggioni et al., reported no difference in attachment between capsule deficient and parent strains (Moscoso, Garcia and Lopez 2006; Oggioni et al. 2006) . In E. coli, the opposite effect has been observed previously. For this bacterium, a mutation in the galU gene led to a decrease of adherent abilities to a polystyrene surface (Genevaux et al. 1999) . Since the composition of extracellular matrix in biofilms differs between streptococcal serotypes, it is possible that the effect of the galU mutation on this matrix differs between serotypes (Allegrucci et al. 2006) . Another explanation could be that the overall metabolism of mutant strains differs from that of their respective wild type strains as it does in E. coli, giving rise to differences in biofilm biomass (Barupal et al. 2013) . Interestingly, there is an effect of the galU mutation in the non-encapsulated strain R6 on antimicrobial susceptibility towards β-lactam antibiotics. β-lactam antibiotics interfere with the peptidoglycan layer of the cell wall. Therefore, the increase in antimicrobial susceptibility towards this group of antibiotics in an already non-encapsulated strain indicates a broader involvement of UDPG:PP in the bacterial metabolism besides capsular polysaccharide production. In E. coli, UDP-glucose is used as an intracellular proxy for nutrient-dependent size control. An imbalance in the amount of intracellular UDP-glucose will impact cell size and other metabolic processes (Hill et al. 2013) . These underlying processes could also impact biofilm formation and biomass.
Taken all in vitro data together, there seems to be a trend between the effect of a galU mutation and biofilm production, Strain 88, C. Strain M23, D. Strain R6. Larvae were considered dead when they displayed no movement in response to shaking of the petri dish or touch with a pipette and were melanized. Error bars represent SE. Larval groups infected with mutant strains of strains 85, 88 and M23 show a significant difference in survival compared to groups infected with the respective wild type strain (Survival analysis, P ≤ 0.05). There is no significant difference in survival between wild type strain 6 and its mutant strain (Survival analysis, P = 0.5683). (n = 5 × 15).
attachment to an abiotic surface and adherence to and phagocytosis in cells. Parent strain M23 produced significantly more capsule compared to the other encapsulated parent strains and as a mutant its capsule was least attenuated. Also the biofilm production was lowest for this strain, as was attachment to the abiotic well plate surface, adherence to epithelial cells or macrophage adherence and phagocytosis. For strain 85, which produced the least amount of capsule both as parent and mutant strain, the opposite was observed. Non-encapsulated strain R6 showed the highest biofilm production, attachment, adherence and phagocytosis. To further study the biological impact of these differences, an in vivo G. mellonella model was used.
